Literature DB >> 30620619

Lung Cancer Screening Benefits and Harms Stratified by Patient Risk: Information to Improve Patient Decision Aids.

Christina Bellinger1, Paul Pinsky2, Kristie Foley1, Douglas Case1, Ajay Dharod1, David Miller1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30620619      PMCID： PMC6943875          DOI： 10.1513/AnnalsATS.201810-690RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  16 in total

1.  Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

Authors:  Paul F Pinsky; David S Gierada; William Black; Reginald Munden; Hrudaya Nath; Denise Aberle; Ella Kazerooni
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

2.  False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.

Authors:  Paul F Pinsky; Christina R Bellinger; David P Miller
Journal:  J Med Screen       Date:  2017-09-20       Impact factor: 2.136

3.  Patient and Clinician Perspectives on Shared Decision-making in Early Adopting Lung Cancer Screening Programs: a Qualitative Study.

Authors:  Renda Soylemez Wiener; Elisa Koppelman; Rendelle Bolton; Karen E Lasser; Belinda Borrelli; David H Au; Christopher G Slatore; Jack A Clark; Hasmeena Kathuria
Journal:  J Gen Intern Med       Date:  2018-02-21       Impact factor: 5.128

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

5.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

6.  Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.

Authors:  John Gohagan; Pamela Marcus; Richard Fagerstrom; Paul Pinsky; Barnett Kramer; Philip Prorok
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

7.  The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.

Authors:  Paul F Pinsky; Timothy R Church; Grant Izmirlian; Barnett S Kramer
Journal:  Cancer       Date:  2013-08-26       Impact factor: 6.860

8.  Evaluating Shared Decision Making for Lung Cancer Screening.

Authors:  Alison T Brenner; Teri L Malo; Marjorie Margolis; Jennifer Elston Lafata; Shynah James; Maihan B Vu; Daniel S Reuland
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

9.  Patient Decision Aids to Engage Adults in Treatment or Screening Decisions.

Authors:  Dawn Stacey; France Légaré; Krystina B Lewis
Journal:  JAMA       Date:  2017-08-15       Impact factor: 56.272

10.  Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Authors:  Martin C Tammemägi; Timothy R Church; William G Hocking; Gerard A Silvestri; Paul A Kvale; Thomas L Riley; John Commins; Christine D Berg
Journal:  PLoS Med       Date:  2014-12-02       Impact factor: 11.069
View more
  2 in total

1.  A Comparison of Smoking History in the Electronic Health Record With Self-Report.

Authors:  Nikhil Patel; David P Miller; Anna C Snavely; Christina Bellinger; Kristie L Foley; Doug Case; Malcolm L McDonald; Youssef R Masmoudi; Ajay Dharod
Journal:  Am J Prev Med       Date:  2020-01-23       Impact factor: 5.043

2.  Outcomes of Shared Decision-Making for Low-Dose Screening for Lung Cancer in an Academic Medical Center.

Authors:  Jan M Eberth; Anja Zgodic; Scott C Pelland; Stephanie Y Wang; David P Miller
Journal:  J Cancer Educ       Date:  2022-04-30       Impact factor: 2.037
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.